← Leaderboards
Yun Sok Lee
University Of California, San Diego
$2,488,189
Attributed
$3,057,406
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $970.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,057,406 · 2
By mechanism
R01$3,057,406 · 2
Top collaborators
- Ayako Makino3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Ayako Makino$7,340,243
- Mana M Parast$19,085,980
- Christopher K Glass$71,096,171
- David M Roth$6,970,274
- Wei Ying$3,312,051
Others in their field
Other Emerging Leaders on “Functional Disorder”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$87,027,148
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$28,495,187
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Barbara Halina Braffett · George Washington University$22,016,904
Research focus
Functional DisorderChronicMolecularTissuesEpidemicDiabetes MellitusMacrophageMediatingPhenotypeReportingPlayExhibitsAnti-Inflammatory AgentsMortalityInflammationInflammatoryAutomobile DrivingGlucose Metabolism DisordersGene ExpressionAdipose TissueGlucose IntoleranceGrowthExosomeExtracellular
Grant awards (8)
Coronary Endothelial Cell Dysfunction in Diabetes: Role of MFGE8$547,334
R01 · FY2025 · HL
ANT2 in metaflammation and insulin resistance$355,501
R01 · FY2025 · DK · contact PI
Coronary Endothelial Cell Dysfunction in Diabetes: Role of MFGE8$570,910
R01 · FY2024 · HL
ANT2 in metaflammation and insulin resistance$379,200
R01 · FY2024 · DK · contact PI
Coronary Endothelial Cell Dysfunction in Diabetes: Role of MFGE8$20,190
R01 · FY2024 · HL
ANT2 in metaflammation and insulin resistance$395,000
R01 · FY2023 · DK · contact PI
ANT2 in metaflammation and insulin resistance$395,000
R01 · FY2022 · DK · contact PI
ANT2 in metaflammation and insulin resistance$394,271
R01 · FY2021 · DK · contact PI